Damage-associated molecular patterns (DAMPs) and mesenchymal stem cells: A matter of attraction and excitement

European Journal of Immunology

Volumn 41, Issue 7, 2011, Pages 1828-1831

  Pistoia, Vito ^a   Raffaghello, Lizzia ^a  

^a G GASLINI INSTITUTE   (Italy)

Author keywords

Immune regulation; Stem cells; Tumor immunology

Indexed keywords

GAMMA INTERFERON; HIGH MOBILITY GROUP B1 PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDOLEAMINE 2,3 DIOXYGENASE; JANUS KINASE; STAT1 PROTEIN; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4;

CELL ACTIVATION; CELL DEATH; CELL MIGRATION; CELL PROLIFERATION; DAMAGE ASSOCIATED MOLECULAR PATTERN; HUMAN; IMMUNOREGULATION; LYMPHOCYTE PROLIFERATION; MESENCHYMAL STEM CELL; NOTE; OXIDATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN SECRETION; SIGNAL TRANSDUCTION; TUMOR CELL; TUMOR MICROENVIRONMENT;

ANIMALS; CELL HYPOXIA; CELL MOVEMENT; CELL PROLIFERATION; HMGB1 PROTEIN; HUMANS; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; INFLAMMATION; MESENCHYMAL STEM CELLS; MODELS, BIOLOGICAL; NECROSIS; NEOPLASMS; NEOVASCULARIZATION, PHYSIOLOGIC; OXIDATION-REDUCTION; TUMOR MICROENVIRONMENT;

EID: 79959744926     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201141724     Document Type: Note

References (17)

1. Sims, G. P., Rowe, D. C., Rietdijk, S. T., Herbst, R. and Coyle, A. J., HMGB1 and RAGE in inflammation and cancer. Annu. Rev. Immunol 2010. 28: 367-388.
2. Uccelli, A., Moretta, L. and Pistoia, V., Mesenchymal stem cells in health and disease. Nat. Rev. Immunol. 2008. 8: 726-736.
3. Le Blanc, K., Frassoni, F., Ball, L., Locatelli, F., Roelofs, H., Lewis, I., Lanino, E. et al., Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet 2008. 371: 1579-1586.
4. Sordi, V., Malosio, M. L., Marchesi, F., Mercalli, A., Melzi, R., Giordano, T., Belmonte, N. et al., Bone marrow mesenchymal stem cells express a restricted set of functionally active chemokine receptors capable of promoting migration to pancreatic islets. Blood 2005. 106: 419-427.
5. Ip, J. E., Wu, Y., Huang, J., Zhang, L., Pratt, R. E. and Dzau, V. J., Mesenchymal stem cells use integrin beta1 not CXC chemokine receptor 4 for myocardial migration and engraftment. Mol. Biol. Cell 2007. 18: 2873-2882.
6. Prowse, A. B., Chong, F., Gray, P. P. and Munro, T. P., Stem cell integrins: implications for ex-vivo culture and cellular therapies. Stem Cell Res. 2011. 6: 1-12.
7. Herrera, M. B., Bussolati, B., Bruno, S., Morando, L., Mauriello-Romanazzi, G., Sanavio, F., Stamenkovic, I. et al., Exogenous mesenchymal stem cells localize to the kidney by means of CD44 following acute tubular injury. Kidney Int. 2007. 72: 430-441.
8. Spaeth, E., Klopp, A., Dembinski, J., Andreeff, M. and Marini, F., Inflammation and tumor microenvironments: defining the migratory itinerary of mesenchymal stem cells. Gene Ther. 2008. 15: 730-738.
9. Lee, R. H., Pulin, A. A., Seo, M. J., Kota, D. J., Ylostalo, J., Larson, B. L., Semprun-Prieto, L. et al., Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Cell Stem Cell 2009. 5: 54-63.
10. Lotfi, R., Eisenbacher, J., Solgi, G., Fuchs, K., Yildiz, T., Nienhaus, C., Rojewski, M. T. and Schrezenmeier, H., Human mesenchymal stem cells (MSCs) respond to native but not oxidized damage associated molecular pattern molecules (DAMPs) from necrotic (tumor) material. Eur. J. Immunol. 2011. 41: 2021-2028.
11. Bell, C. W., Jiang, W., Reich III, C. F. and Pisetsky, D. S., The extracellular release of HMGB1 during apoptotic cell death. Am. J. Physiol. Cell Physiol. 2006. 291: C1318-1325.
12. Meng, E., Guo, Z., Wang, H., Jin, J., Wang, J., Wang, H., Wu, C. and Wang, L., High mobility group box 1 protein inhibits the proliferation of human mesenchymal stem cells and promotes their migration and differentiation along osteoblastic pathway. Stem Cells Dev. 2008. 17: 805-813.
13. Spaeth, E. L., Dembinski, J. L., Sasser, A. K., Watson, K., Klopp, A., Hall, B., Andreeff, M. and Marini, F., Mesenchymal stem cell transition to tumor-associated fibroblasts contributes to fibrovascular network expansion and tumor progression. PLoS One 2009. 4: e4992.
14. Haniffa, M. A., Collin, M. P., Buckley, C. D. and Dazzi, F., Mesenchymal stem cells: the fibroblasts' new clothes? Haematologica 2009. 94: 258-263.
15. Bocelli-Tyndall, C., Barbero, A., Candrian, C., Ceredig, R., Tyndall, A. and Martin, I., Human articular chondrocytes suppress in vitro proliferation of anti-CD3 activated peripheral blood mononuclear cells. J. Cell. Physiol. 2006. 209: 732-734.
16. Bennett, M., Feldmeier, J., Smee, R. and Milross, C., Hyperbaric oxygenation for tumour sensitisation to radiotherapy: a systematic review of randomised controlled trials. Cancer Treat. Rev. 2008. 34: 577-591.
17. Yanai, H., Ban, T., Wang, Z., Choi, M. K., Kawamura, T., Negishi, H., Nakasato, M. et al., HMGB proteins function as universal sentinels for nucleic-acid-mediated innate immune responses. Nature 2009. 462: 99-103.